Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006823-38Phase 3Completed
Phase 3, open-label trial of phenprocoumon and warfarin in venous thromboembolism (VTE) (2 arms), sponsored by University of Bonn. Primary endpoint: Recurrence of objectively documented venous thromboembolism. Started May 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006823-38.